sch 51048 has been researched along with fluconazole in 2 studies
Studies (sch 51048) | Trials (sch 51048) | Recent Studies (post-2010) (sch 51048) | Studies (fluconazole) | Trials (fluconazole) | Recent Studies (post-2010) (fluconazole) |
---|---|---|---|---|---|
7 | 0 | 0 | 9,343 | 721 | 3,664 |
Protein | Taxonomy | sch 51048 (IC50) | fluconazole (IC50) |
---|---|---|---|
Lanosterol 14-alpha demethylase | Candida albicans SC5314 | 0.1296 | |
Cytochrome P450 2C9 | Homo sapiens (human) | 9.21 | |
Sterol 14-alpha demethylase | Trypanosoma cruzi strain CL Brener | 0.88 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Clemons, KV; Homola, ME; Stevens, DA | 1 |
Anaissie, EJ; Dignani, MC; Karyotakis, NC | 1 |
2 other study(ies) available for sch 51048 and fluconazole
Article | Year |
---|---|
Activities of the triazole SCH 51048 against Coccidioides immitis in vitro and in vivo.
Topics: Animals; Antifungal Agents; Coccidioides; Coccidioidomycosis; Female; Fluconazole; Half-Life; Itraconazole; Mice; Microbial Sensitivity Tests; Triazoles | 1995 |
SCH 51048, a new antifungal triazole active against hematogenous Candida krusei infections in neutropenic mice.
Topics: Amphotericin B; Animals; Antifungal Agents; Candidiasis; Fluconazole; Immunosuppression Therapy; Kidney; Male; Mice; Mice, Inbred Strains; Neutropenia; Triazoles | 1995 |